SCHEMBL18239059

SCHEMBL18239059

CC(C)c1ccc(C(=O)c2ncc(-c3cnc4[nH]cc(C=CC(N)=O)c4c3)cc2F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 6/20 0.38
▸ MAP3K7 O43318 4/20 0.37
▸ TAB1 Q15750 4/20 0.37
▸ SGK1 O00141 3/20 0.37
▸ MAP3K11 Q16584 2/20 0.37
▸ AAK1 Q2M2I8 2/20 0.36
▸ ITK Q08881 3/20 0.35
▸ BTK Q06187 2/20 0.35
▸ CDC7 O00311 1/20 0.35
▸ PLK4 O00444 1/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ MAPK13 O15264 1/20 0.35
▸ PDPK1 O15530 1/20 0.35
▸ DYRK3 O43781 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ RPS6KA5 O75582 1/20 0.35
▸ PRKD3 O94806 1/20 0.35
▸ PAK4 O96013 1/20 0.35
▸ CHEK2 O96017 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16949003 1.00 AXL (0.38) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL18238284 0.90 ITK (0.41) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL16948748 0.90 ITK (0.41) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL18250476 0.90 AXL (0.39) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL16949002 0.90 AAK1 (0.42) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL18238690 0.90 AAK1 (0.42) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL16948892 0.90 AAK1 (0.42) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL18238621 0.90 AAK1 (0.42) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL16949144 0.89 SGK1 (0.43) AXLMAP3K7TAB1SGK1MAP3K11
SCHEMBL18238754 0.89 SGK1 (0.43) AXLMAP3K7TAB1SGK1MAP3K11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499551-B2 Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases CONFLUENCE LIFE SCIENCES, INC. (US) 2016-11-22 — — US disclosed
Send feedback